000144805 001__ 144805
000144805 005__ 20250923084431.0
000144805 0247_ $$2doi$$a10.1111/ijd.17366
000144805 0248_ $$2sideral$$a139601
000144805 037__ $$aART-2024-139601
000144805 041__ $$aeng
000144805 100__ $$aChernyshov, Pavel Viktorovich
000144805 245__ $$aQuality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement
000144805 260__ $$c2024
000144805 5203_ $$aIn this study, the European Academy of Dermatology and Venereology (EADV) Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema has examined the Health‐Related Quality of Life (HRQoL) measurement in the treatment of urticaria. The Dermatology Life Quality Index was the most frequently used HRQoL instrument in clinical trials on urticaria. Many reports of clinical trials of urticaria gave no exact numeric results related to HRQoL changes, making clear conclusions and comparisons with other studies impossible. The interpretation of HRQoL impairment data is more difficult when assessed by instruments without severity stratification systems. The minimal clinically significant difference (MCID) is a more clinically oriented and relevant parameter than depending on statistically significant changes in HRQoL scores. Therefore, using HRQoL instruments with established MCID data in clinical trials and clinical practice is preferred.
000144805 540__ $$9info:eu-repo/semantics/closedAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000144805 590__ $$a3.2$$b2024
000144805 592__ $$a0.822$$b2024
000144805 591__ $$aDERMATOLOGY$$b22 / 96 = 0.229$$c2024$$dQ1$$eT1
000144805 593__ $$aDermatology$$c2024$$dQ1
000144805 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000144805 700__ $$0(orcid)0000-0003-1917-6906$$aTomas-Aragones, Lucia
000144805 700__ $$aZuberbier, Torsten
000144805 700__ $$aKocatürk, Emek
000144805 700__ $$aManolache, Liana
000144805 700__ $$aPustisek, Nives
000144805 700__ $$aSvensson, Åke
000144805 700__ $$aMarron, Servando E.
000144805 700__ $$aSampogna, Francesca
000144805 700__ $$aBewley, Anthony
000144805 700__ $$aSalavastru, Carmen
000144805 700__ $$aKoumaki, Dimitra
000144805 700__ $$aAugustin, Matthias
000144805 700__ $$aLinder, Dennis
000144805 700__ $$aAbeni, Damiano
000144805 700__ $$aSalek, Sam S.
000144805 700__ $$aSzepietowski, Jacek C.
000144805 700__ $$aJemec, Gregor B.
000144805 773__ $$g63, 12 (2024), 1657-1667$$pInt. j. dermatol.$$tINTERNATIONAL JOURNAL OF DERMATOLOGY$$x0011-9059
000144805 8564_ $$s231398$$uhttps://zaguan.unizar.es/record/144805/files/texto_completo.pdf$$yVersión publicada
000144805 8564_ $$s1812591$$uhttps://zaguan.unizar.es/record/144805/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000144805 909CO $$ooai:zaguan.unizar.es:144805$$particulos$$pdriver
000144805 951__ $$a2025-09-22-14:43:07
000144805 980__ $$aARTICLE